Effectiveness of Iguratimod Versus Placebo to Treat Early Rheumatoid Arthritis on MRI
Clinical trial NCT01893151 · UNKNOWN
Trial details
- NCT number
- NCT01893151
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2015-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.